Clinical Trials
4 trialsNCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT04776005 2024-01-03
COVIDVAC OH
Assistance Publique - Hôpitaux de Paris
Unknown
NCT02530515 2019-10-29
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01476462 2012-05-24
PdL-SMN1
Rigshospitalet, Denmark
Completed